CDE Detailed Report

Disease: Stroke
Sub-Domain: Drugs
CRF: Prior and Concomitant Medications

Displaying 1 - 50 of 72
CDE ID CDE Name Variable Name Definition Short Description Additional Notes (Question Text) Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guideline) Sub Domain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type External Id Loinc External Id Snomed External Id caDSR External Id CDISC
C58987 Medication other antihypertensive past week text MedctnOthrAnthyprtnsvPastWkTxt The free-text field related to 'Medication other antihypertensive past week type', specifying text The free-text field related to 'Medication other antihypertensive past week type', specifying text Other antihypertensive, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:02:52.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54994 Potency enhancing drug current former use type PotncyEnhanceDrugCurrFrmrUsTyp Type of potency-enhancing drug formerly or currently taken by the subject/participant Type of potency-enhancing drug formerly or currently taken by the subject/participant Type of potency-enhancing drug used Sildenafil (Viagra);Avanafil (Stendra);Tadalafil (Cialis);Vardenafil (Levitra) Sildenafil (Viagra);Avanafil (Stendra);Tadalafil (Cialis);Vardenafil (Levitra) Alphanumeric

Was the participant/ subject taking any of the following medications prior to admission or at the time of evaluation?

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 13:56:57.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C58966 Medication anticoagulant past week other text MedctnAnticoaglntPastWkOTH The free-text field related to 'Medication anticoagulant past week type', specifying other text The free-text field related to 'Medication anticoagulant past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:42:16.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58998 Medication ADHD ADD current former take indicator MedctnADHDADDCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD) medications The indicator relating to whether the subject/participant has formerly or currently taken Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD) medications Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD) medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

This element is recommended for pediatric stroke studies.
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Pediatric Exploratory 1.00 2020-08-13 15:40:59.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58977 Medication diuretic past week other text MedctnDiureticPastWkOTH The free-text field related to 'Medication diuretic past week type', specifying other text The free-text field related to 'Medication diuretic past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 11:38:49.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C18827 Gastrointestinal therapy nutrition supplement other text GITherpyNutritionSupplementOTH The free-text field related to 'Gastrointestinal therapy nutrition supplement type' specifying other text. Type(s) of nutritional supplement(s) being taken by the participant/subject The free-text field related to 'Gastrointestinal therapy nutrition supplement type' specifying other text. Type(s) of nutritional supplement(s) being taken by the participant/subject Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Exploratory 3.00 2013-07-24 11:38:01.2 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

2183828
C58988 Medication hormone replacement current former take indicator MedctnHrmneRplcmtCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken hormonal replacement medications The indicator relating to whether the subject/participant has formerly or currently taken hormonal replacement medications Hormonal Replacement Medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:05:06.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C54995 Potency enhancing drug current former use duration PotencyEnhncngCurrFrmrUseDur Duration in months for which the subject/participant took or has taken the specified potency-enhancing drug Duration in months for which the subject/participant took or has taken the specified potency-enhancing drug Duration of Use (months) Numeric Values

No instructions available

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Months
C58967 Medication cholesterol reduce control current former take indicator MedctnCholRdcCtrlCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken cholesterol-reducing/ controlling medications The indicator relating to whether the subject/participant has formerly or currently taken cholesterol-reducing/ controlling medications Cholesterol-reducing/ controlling medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:43:16.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58999 Medication cold preparation current former take indicator MedctnColdPrepCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken cold preparations/ medications The indicator relating to whether the subject/participant has formerly or currently taken cold preparations/ medications Cold preparations/ medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

This element is recommended for pediatric stroke studies.
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Pediatric Exploratory 1.00 2020-08-13 15:42:22.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58978 Medication beta-blocker past week type MedctnBetaBlockerPastWkTyp Type of beta-blocker medication taken by the subject/participant within the past week Type of beta-blocker medication taken by the subject/participant within the past week If beta-blocker history, indicate medication(s) the patient took within the past week Propranolol;Atenolol;Metoprolol;Carvedilol;Other, specify Propranolol;Atenolol;Metoprolol;Carvedilol;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 11:39:46.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54985 Stimulant current former use type StimulantCurrFrmrUseTyp Type of stimulant formerly or currently taken by the subject/participant Type of stimulant formerly or currently taken by the subject/participant Stimulants Amphetamine derivatives;Caffeine;Theophylline;Modafinil;Other, specify;Phentermine Amphetamine derivatives;Caffeine (Xanthine derivative);Theophylline (Xanthine derivative);Modafinil;Other, specify;Phentermine Alphanumeric

Was the participant/ subject taking any of the following medications prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 13:56:57.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58989 Medication hormone replacement past week type MedctnHrmneRplcmtPastWkTyp Type of hormone replacement medication taken by the subject/participant within the past week Type of hormone replacement medication taken by the subject/participant within the past week If YES, indicate medication(s) the patient took within the past week Estrogen;Combination of Estrogen and Progesterone;Progesterone;Testosterone;Other, specify Estrogen;Combination of Estrogen and Progesterone;Progesterone;Testosterone;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:12:54.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54996 Potency enhancing drug current former use age start value PtncyEnhcgDrgCurFmrUsAgStrtVal Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug Age when use started (years) Numeric Values

No instructions available

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Years
C58968 Medication cholesterol reduce control past week type MedctnCholRdcCtrlPastWkTyp Type of cholesterol-reducing/ controlling medication taken by the subject/participant within the past week Type of cholesterol-reducing/ controlling medication taken by the subject/participant within the past week If YES, indicate medication(s) the patient took within the past week Statin;Fibrate;Ezetimibe;Other, specify Statin;Fibrate;Ezetimibe;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:44:18.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C59000 Medication L-asparaginase current former take indicator MedctnLASPCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken L-asparaginase The indicator relating to whether the subject/participant has formerly or currently taken L-asparaginase L-asparaginase No;Yes;Unknown No;Yes;Unknown Alphanumeric

This element is recommended for pediatric stroke studies.
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Pediatric Exploratory 1.00 2020-08-13 15:43:06.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58979 Medication beta-blocker past week other text MedctnBetaBlockerPastWkOTH The free-text field related to 'Medication beta-blocker past week type', specifying other text The free-text field related to 'Medication beta-blocker past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:14:14.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54986 Stimulant current former use other text StimulantCurrFrmrUseOTH The free-text field related to 'Stimulant current former use type' specifying other text The free-text field related to 'Stimulant current former use type' specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:30:43.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 50

Free-Form Entry

C58990 Medication hormone replacement past week other text MedctnHrmneRplcmtPastWkOTH The free-text field related to 'Medication hormone replacement past week type', specifying text The free-text field related to 'Medication hormone replacement past week type', specifying text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:18:32.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54997 Potency enhancing drug former use age end value PotncyEnhancgDrugFmrUsAgEndVal Age in years at which the subject/participant stopped taking the specified potency-enhancing drug Age in years at which the subject/participant stopped taking the specified potency-enhancing drug Age when use ended (years) Numeric Values

No instructions available

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Years
C58969 Medication cholesterol reduce control past week other text MedctnCholRdcCtrlPastWkOTH The free-text field related to 'Medication cholesterol reduce control past week type', specifying other text The free-text field related to 'Medication cholesterol reduce control past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:45:06.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58980 Medication angiotensin receptor blocker past week type MedctnAngtsnRcptrBlkrPastWkTyp Type of angiotensin receptor blocker (ARB) medication taken by the subject/participant within the past week Type of angiotensin receptor blocker (ARB) medication taken by the subject/participant within the past week If angiotensin receptor blocker (ARB) history, indicate medication(s) the patient took within the past week Candesartan;Losartan;Other, specify Candesartan;Losartan;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:15:16.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54987 Stimulant current former use duration SimulantCurFrmrUseDur Duration in months for which the subject/participant took or has taken the selected former or current stimulant Duration in months for which the subject/participant took or has taken the selected former or current stimulant Duration of Use (months) Numeric Values

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Months
C58991 Medication hormone replacement therapy route type MedctnHrmneRplcmtTherpyRteTyp Type of administration route for the hormone replacement therapy medication taken by the subject/participant within the past week Type of administration route for the hormone replacement therapy medication taken by the subject/participant within the past week If YES, indicate the route of hormonal replacement therapy Oral;Topical;Transdermal;Other, specify;Unknown Oral;Topical;Transdermal;Other, specify;Unknown Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:20:24.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54998 Medication immunosuppressant current former type MedctnImnosprsntCurrFrmrTyp Type of immunosuppressant medication formerly or currently taken by the subject/participant Type of immunosuppressant medication formerly or currently taken by the subject/participant Immunosuppressants Corticosteroids local;Corticosteroids systemic;Other, specify: Corticosteroids local;Corticosteroids systemic;Other, specify: Alphanumeric

Was the participant/ subject taking any of the following medications prior to admission or at the time of evaluation?

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 13:56:57.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58970 PCSK9 inhibitor past three month indicator PCSK9InhibitorPastThreeMoInd The indicator related to whether the subject/participant was taking PCSK9 inhibitors (alirocumab, evolocumab) within the past three months The indicator related to whether the subject/participant was taking PCSK9 inhibitors (alirocumab, evolocumab) within the past three months If YES, was patient taking PCSK9 inhibitors within past three months (alirocumab, evolocumab) No;Yes;Unknown No;Yes;Unknown Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:45:46.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58981 Medication angiotensin receptor blocker past week other text MedctnAngtRtrBlkrPastWkOTH The free-text field related to 'Medication angiotensin receptor blocker past week type', specifying other text The free-text field related to 'Medication angiotensin receptor blocker past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:23:35.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54988 Stimulant current former use age start value StimulantCurFmrUsAgSttVal Age in years at which the subject/participant began taking the selected former or current stimulant Age in years at which the subject/participant began taking the selected former or current stimulant Age at Start (years) Numeric Values

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Years
C58992 Medication hormone replacement therapy route other text MedctnHrmnRplcmThrpyRteOTH The free-text field related to 'Medication hormone replacement therapy route type', specifying text The free-text field related to 'Medication hormone replacement therapy route type', specifying text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:31:46.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54999 Medication immunosuppressant current former take other text MedctnImnosprsntCurrFrmrTkOTH The free-text field related to 'Medication immunosuppressant current former type' specifying other text The free-text field related to 'Medication immunosuppressant current former type' specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Exploratory 1.00 2017-04-13 14:30:43.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58971 Medication diabetic current former take indicator MedctnDiabeticCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken diabetic medications The indicator relating to whether the subject/participant has formerly or currently taken diabetic medications Diabetic medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:46:43.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58982 Medication calcium-channel blocker past week type MedctnCaChannlBlockerPastWkTyp Type of calcium-channel blocker medication taken by the subject/participant within the past week Type of calcium-channel blocker medication taken by the subject/participant within the past week If calcium-channel blocker history, indicate medication(s) the patient took within the past week Verapamil;Felodipine;Amlodipine;Diltiazem;Other, specify Verapamil;Felodipine;Amlodipine;Diltiazem;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:25:08.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54989 Stimulant former use age end value StimulantFmrUseAgEndVal Age in years at which the subject/participant stopped taking the selected former stimulant Age in years at which the subject/participant stopped taking the selected former stimulant Age at End (years) Numeric Values

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Years
C58993 Medication oral contraceptive current former take indicator MedctnOrlCntrcptvCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken oral contraceptives The indicator relating to whether the subject/participant has formerly or currently taken oral contraceptives Oral contraceptives No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:32:39.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58961 Medication antiplatelet current former take indicator MedctnAntiplatltCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken antiplatelet medications The indicator relating to whether the subject/participant has formerly or currently taken antiplatelet medications Antiplatelets No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:24:19.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58972 Medication diabetic past week type MedctnDiabeticPastWkTyp Type of diabetic medication taken by the subject/participant within the past week Type of diabetic medication taken by the subject/participant within the past week If YES, indicate medication(s) the patient took within the past week 2nd generation sulfonylurea (glyburide, glipizide, glimepiride);Thiazolidinedione (rosiglitazone, pioglitazone);Repaglinide/ Nateglinide;Insulin;Metformin;Acarbose;1st generation sulfonylurea (chlorpropamide);Other, specify 2nd generation sulfonylurea (glyburide, glipizide, glimepiride);Thiazolidinedione (rosiglitazone, pioglitazone);Repaglinide/ Nateglinide;Insulin;Metformin;Acarbose;1st generation sulfonylurea (chlorpropamide);Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:48:14.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C58983 Medication calcium-channel blocker past week other text MedctnCaChnlBlckrPastWkOTH The free-text field related to 'Medication calcium-channel blocker past week type', specifying other text The free-text field related to 'Medication calcium-channel blocker past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:36:15.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54990 Cocaine expose year prior unruptured intracranial aneurysm presentation indicator CokeExposeYearPriorUIAPrsntInd Indicator of whether the subject/participant was exposed to cocaine in the year prior to clinical presentation of unruptured intracranial aneurysm (UIA) Indicator of whether the subject/participant was exposed to cocaine in the year prior to clinical presentation of unruptured intracranial aneurysm (UIA) Cocaine: Exposure to cocaine within one year of clinical presentation of UIA No;Yes No;Yes Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 15:52:12.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58994 Medication implant estrogen contraceptive current former take indicator MedctnImpEstCtrcpCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken implanted, estrogen-containing contraceptives The indicator relating to whether the subject/participant has formerly or currently taken implanted, estrogen-containing contraceptives Implanted, estrogen-containing contraceptives No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 14:34:08.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58962 Medication antiplatelet past week type MedctnAntiplatltPastWkTyp Type of antiplatelet medication taken by the subject/participant within the past week Type of antiplatelet medication taken by the subject/participant within the past week If YES, indicate medication(s) the patient took within the past week ASA/Dipyridamole (in separate formulations or as Aggrenox);Aspirin (ASA);Clopidogrel (Plavix);Cilostazol (Pletal);Ticlopidine (Ticlid);Ticagrelor (Brilinta);Prasugrel (Effient);Other, specify;Pentoxifylline (Trental) ASA/Dipyridamole (in separate formulations or as Aggrenox);Aspirin (ASA);Clopidogrel (Plavix);Cilostazol (Pletal);Ticlopidine (Ticlid);Ticagrelor (Brilinta);Prasugrel (Effient);Other, specify;Pentoxifylline (Trental) Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:26:49.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C58973 Medication diabetic past week other text MedctnDiabeticPastWkOTH The free-text field related to 'Medication diabetic past week type', specifying other text The free-text field related to 'Medication diabetic past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 11:10:34.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58984 Medication ACE inhibitor past week type MedctnACEInhibitorPastWkTyp Type of ACE (angiotensin-converting enzyme) inhibitor medication taken by the subject/participant within the past week Type of ACE (angiotensin-converting enzyme) inhibitor medication taken by the subject/participant within the past week If ACE inhibitor history, indicate medication(s) the patient took within the past week Enalapril;Lisinopril;Fosinopril;Ramipril (Altace);Captopril;Other, specify Enalapril;Lisinopril;Fosinopril;Ramipril (Altace);Captopril;Other, specify Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:37:30.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C54991 Cocaine use duration CocaineUseDur Duration in months for which the subject/participant took or has taken cocaine Duration in months for which the subject/participant took or has taken cocaine Duration of Use (months) Numeric Values

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Months
C58963 Medication antiplatelet past week other text MedctnAntiplatltPastWkOTH The free-text field related to 'Medication antiplatelet past week type', specifying other text The free-text field related to 'Medication antiplatelet past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:32:41.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58995 Medication other current former take indicator MedctnOthrCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken other medications The indicator relating to whether the subject/participant has formerly or currently taken other medications Any other medications not already listed No;Yes;Unknown No;Yes;Unknown Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 15:17:35.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58974 Medication antihypertensive current former take indicator MedctnAntihyprtnsCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken antihypertensive medications The indicator relating to whether the subject/participant has formerly or currently taken antihypertensive medications Antihypertensive medications No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 11:12:02.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58985 Medication ACE inhibitor past week other text MedctnACEInhibitrPastWkOTH The free-text field related to 'Medication ACE inhibitor past week type', specifying other text The free-text field related to 'Medication ACE inhibitor past week type', specifying other text Other, specify Alphanumeric

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 13:48:16.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C54992 Cocaine exposure age start value CocaineExposureAgeStartVal Age in years at which the subject/participant began exposure to cocaine Age in years at which the subject/participant began exposure to cocaine Age when use started (years) Numeric Values

No instructions available

No references available Adult;Pediatric Supplemental 1.00 2017-04-13 14:32:36.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Free-Form Entry

Years
C58964 Medication anticoagulant current former take indicator MedctnAnticoaglntCurrFrmrTkInd The indicator relating to whether the subject/participant has formerly or currently taken anticoagulant medications The indicator relating to whether the subject/participant has formerly or currently taken anticoagulant medications Anticoagulants No;Yes;Unknown No;Yes;Unknown Alphanumeric

Was the participant/ subject taking the following medication prior to admission or at the time of evaluation?

No references available Adult;Pediatric Supplemental 1.00 2020-07-30 16:35:40.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58996 Medication other past week type MedctnOthrPastWkTyp Type of other medication taken by the subject/participant within the past week Type of other medication taken by the subject/participant within the past week Type of other medication taken by the subject/participant within the past week Digoxin/cardiac glycosides;Thyroid preparations;Benzodiazepines (Valium, Librium, Ativan, Xanax);Anti-Parkinsonian meds (including selegiline);Non-aspirin salicylates (salsalate);Other nonsteroidal anti-inflammatory drugs;Ginkgo derivatives/other herbals;Vitamin E (more than multivitamins);SSRIs and new-generation antidepressants;Antiarrhythmic drugs (quinidine, amiodarone);Tricyclic antidepressants (amitriptyline, imipramine, doxepin);H2 blocker (e.g., cimetidine) or proton pump inhibitor (e.g., omeprazole);Donepezil and related meds;Analgesics (acetaminophen, codeine)–daily;COX 2 inhibitors (e.g., celecoxib);COX inhibitors (e.g., ibuprofen, naproxen);Multivitamin;Other, specify;Nitrates Digoxin/cardiac glycosides;Thyroid preparations;Benzodiazepines (Valium, Librium, Ativan, Xanax);Anti-Parkinsonian meds (including selegiline);Non-aspirin salicylates (salsalate);Other nonsteroidal anti-inflammatory drugs;Ginkgo derivatives/other herbals;Vitamin E (more than multivitamins);SSRIs and new-generation antidepressants;Antiarrhythmic drugs (quinidine, amiodarone);Tricyclic antidepressants (amitriptyline, imipramine, doxepin);H2 blocker (e.g., cimetidine) or proton pump inhibitor (e.g., omeprazole);Donepezil and related meds;Analgesics (acetaminophen, codeine)–daily;COX 2 inhibitors (e.g., celecoxib);COX inhibitors (e.g., ibuprofen, naproxen);Multivitamin;Other, specify;Nitrates Alphanumeric

Choose all that apply

No references available Adult;Pediatric Supplemental 1.00 2020-08-13 15:21:26.0 Prior and Concomitant Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

CSV